Hostname: page-component-5d84bcc8dc-vfbgv Total loading time: 0 Render date: 2026-09-13T20:04:07.128Z Has data issue: false hasContentIssue false
  • English
  • Français

Translating immuno-metabolic psychiatry: commentary on De Giorgi et al

Published online by Cambridge University Press:  01 September 2026

Rodrigo B. Mansur Open the ORCID record for Rodrigo B. Mansur [Opens in a new window]
Rodrigo B. Mansur*
Affiliation:
University Health Network, Toronto, Canada Department of Psychiatry, University of Toronto, Canada
*
Email: rodrigo.mansur@uhn.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Neuroimmunologyneuroendocrinologypsychotic disorders/schizophreniadepressive disordersbipolar type I or II disorders

Information

Type
Commentary
Information
The British Journal of Psychiatry , First View , pp. 1 - 2
Check for updates
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

De Giorgi, R, Hahn, MK, Cheliotis-James, T, Smith, ECC, Penninx, BWJH, Pillinger, P, et al. Applying immunity and metabolism to psychiatry: lost, or in translation? Br J Psychiatry [Epub ahead of print] 14 Jul 2026. Available from: https://doi.org/10.1192/bjp.2026.10714.Google ScholarPubMed
Chen, YH, Wang, HN, Lang, XE, Zhang, XY. Prevalence and clinical correlates of abnormal glucose metabolism in young, first- episode and medication-naive outpatients with major depressive disorder. Psychiatry Res 2023; 325: 115250.10.1016/j.psychres.2023.115250CrossRefGoogle Scholar
Watson, KT, Simard, JF, Henderson, VW, Nutkiewicz, L, Lamers, F, Nasca, C, et al. Incident major depressive disorder predicted by three measures of insulin resistance: a Dutch Cohort Study. Am J Psychiatry 2021; 178: 914–20.10.1176/appi.ajp.2021.20101479CrossRefGoogle ScholarPubMed
Fanelli, G, Franke, B, De Witte, W, Ruisch, IH, Haavik, J, van Gils, V, et al. Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders. Transl Psychiatry 2022; 12: 59.10.1038/s41398-022-01817-0CrossRefGoogle ScholarPubMed
Fried, EI. Mental disorders as homeostatic property clusters: a narrative review. JAMA Psychiatry 2026; 83: 645–54.10.1001/jamapsychiatry.2026.0073CrossRefGoogle ScholarPubMed
Cooper, JA, Arulpragasam, AR, Treadway, MT. Anhedonia in depression: biological mechanisms and computational models. Curr Opin Behav Sci 2018; 22: 128–35.10.1016/j.cobeha.2018.01.024CrossRefGoogle ScholarPubMed
Gill, H, Badulescu, S, Shah, H, Brudner, RM, Phan, L, Di Vincenzo, JD, et al. Semaglutide and effort-based decision-making in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 2026; 83: 751–4.10.1001/jamapsychiatry.2026.0594CrossRefGoogle ScholarPubMed
De Hert, M, Cohen, D, Bobes, J, Cetkovich-Bakmas, M, Leucht, S, Ndetei, DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011; 10: 138–51.10.1002/j.2051-5545.2011.tb00036.xCrossRefGoogle ScholarPubMed
Lindstrӧm, C, Siersma, V, Kriegbaum, M, Grauers Willadsen, T, Bakkedal, C, Brodersen, JB, et al. Time trends in mortality for people with severe mental illness in Denmark 2000–2018. Nord J Psychiatry 2025; 79: 79–85.10.1080/08039488.2024.2444262CrossRefGoogle Scholar

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.